Vinorelbine Tartrate Injection Clinical Trials

4 actively recruiting trials

No change since May 2026

Pipeline

Phase 3: 3Phase 1/2: 1

Top Sponsors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd2
Shanghai Yizhong Pharmaceutical Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Indications

Breast Cancer4
Cancer4
Metastatic Breast Cancer (MBC)1
Recurrent Breast Cancer1
Advanced Malignancies1

Other4 trials

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

Phase 3

A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

Phase 1/2

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

Phase 3

JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.